Exogenous Ketone Esters for Refractory Status Epileptics
Condition(s) studied
Investigational drug(s) / intervention(s)
Exogenous ketone ester: 500 mg/kg over 5 min administered by nasogastric tube, followed after 1 hr by repeated hourly doses of 125 mg/kg for 8 hrs.
Study summary
This study aims to investigate the efficacy of add-on exogenous ketone esters for the treatment of children with refractory generalized convulsive status epilepticus
Eligibility
Primary outcome measure(s)
- Proportion of patients achieving electroclinical cessation of seizures — 60 minutes
Proportions of patients who achieve cessation of BOTH clinical seizures (as observed clinically) AND electrical seizures (evaluated by electroencephalography \[EEG\])
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Department of Pediatrics at Sohag University Hospital | Sohag | Egypt | Recruiting |
More Sohag University trials in Egypt
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT05674552 on ClinicalTrials.gov ↗ ← All trials in Egypt